Tap Into the $65B 'Shroom Boom'
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD
Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.
Dan Bongino Stunned by FBI's Recent Corruption Findings: 'I'll Never Be the Same After Learning What I've Learned'
FBI Deputy Director Dan Bongino has expressed deep concern over the discoveries of government corruption and weaponization.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Denny's CEO Asks Potential Hires Only Two Questions But Reveals It 'Doesn't Matter What The Questions Are' — Here's Why
Denny's CEO Kelli Valade shares her hiring strategy of looking for red flags and self-awareness through thoughtful questions, not just answers.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
Charles Schwab To Launch Bitcoin, Ethereum Trading Services
Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:
At 14, Jamie Dimon Owned His First Stock, Watched A 45% Market Crash Only To Learn This Investment Lesson: 'History Does Rhyme'
Jamie Dimon, the CEO of JPMorgan Chase & Co., revealed the pivotal investment lesson he learned as a teenager.
Smarter Capital. No Screens. No Noise. - Ad
HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?
Forget 'Wealth': Warren Buffett Says This Word Is the True Measure of Success
Warren Buffett imparted his unique viewpoint on success, underscoring the significance of love and respect over the accumulation of wealth.
Verizon Beats Expectations, Boosts Outlook — Here's Why Analysts Still See More Room To Grow
Verizon's Q2 results beat expectations, driven by wireless and broadband offerings. Analysts raised price targets, but net additions were lower.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Trump, Powell Clash Over $3 Billion Federal Reserve Renovations In Front Of Reporters
President Trump and Fed Chair Jerome Powell have a public disagreement on Thursday at the Federal Reserve building.
Tim Walz: Trump 'Brings Out the Worst in Me'
Gov. Tim Walz (D-Minn.) offered a candid reflection on his rhetoric toward Donald Trump, acknowledging regret over earlier inflammatory comments made during the 2024 presidential campaign.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Hershey and other chocolate makers hike prices as cocoa remains near record highs
Here’s the good news: The Hershey Co. says it’s not raising prices for this year.
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Robert Kiyosaki Advocates for Gold and Bitcoin Over Dollar Savings: 'It Is Smarter and Safer'
Renowned financial educator Robert Kiyosaki recently expressed his preference for gold and Bitcoin (CRYPTO: BTC) over saving in dollars,
Elon Musk's Tesla Sits On $284 Million Bitcoin Windfall In Q2, Refuses to Cash Out
Electric vehicle behemoth Tesla Inc.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Wallis Annenberg, billionaire philanthropist who backed arts, science and other causes, dies at 86
LOS ANGELES (AP) — Wallis Annenberg, the billionaire philanthropist who supported the arts, science, education and animal welfare causes over decades in Los Angeles, died Monday, her family said.
Wisconsin man pleads guilty to smuggling lab equipment to Russian companies
MADISON, Wis. (AP) — A Wisconsin man pleaded guilty Tuesday to smuggling lab equipment to Russian companies in violation of trade sanctions the United States imposed after Russia invaded Ukraine.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Why AGCO Stock Is Surging After Q2 Results
AGCO reports strong Q2 results, exceeding expectations in a challenging agricultural market. Shares rose as 2025 guidance was raised.
Trump administration appeals to Supreme Court to allow $783 million research-funding cuts
WASHINGTON (AP) — The Trump administration asked the on Thursday to allow it to cut hundreds of millions of dollars’ worth of research funding in its push to roll back federal diversity, equity and inclusion efforts.
Is Your Capital Following a Real Strategy? - Ad
Trade with $100K-$200K funded capital-no manual trading. Our AI system skips charts, eliminates stress, and lands you funding. Thousands passed prop challenges with us. Apply now, book a call, and have $10K ready.
Britain and Australia to sign 50-year nuclear submarine treaty
MELBOURNE, Australia (AP) — Britain and Australia announced they will sign a cooperation treaty to build Australian nuclear-powered submarines and welcomed a review by administration of the United States' role in the trilateral defense deal.
Tesla Rivals BYD, Toyota, VW, GM Accused Of Faking Car Sales In China To Hit Targets: Report
Auto brands in China accused of inflating sales figures amid fierce competition to meet sales targets, leading to misjudgment of demand.
Trading Isn't Your Job. Let the System Handle It. - Ad
HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?
Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US
HERMOSILLO, Mexico (AP) — The United States’ suspension of live cattle imports from Mexico hit at the worst possible time for rancher Martín Ibarra Vargas, who after two years of severe drought had hoped to put his family on better footing selling his calves across the northern border.
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?
Elevance Health and Waters led the weekly large-cap losers, hit by weak earnings, lowered guidance, and analyst downgrades.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Ethereum, XRP, SOL Surge After GENIUS Act: What's Driving The Altcoin Rally?
The altcoin rally may only be getting started and follows the signing of the GENIUS Act, the most significant U.S. crypto legislation to date, ushering in structural clarity for digital assets.
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.
Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
Samsung Electronics Shares Fall 2.54% Following Tesla's $16.5 Billion AI Chip Manufacturing Agreement
Samsung Electronics Co. Ltd. shares declined 2.54% following Tesla Inc.'s confirmation of a $16.5 billion chip manufacturing partnership.
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.